Syon Capital’s Novo Nordisk NVO Stock Holding History

Syon Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$411K	Sell	8,565 -2,783	-25%	-$120K	0.02%	702
2026 Q1	$417K	Buy	11,348 +1,064	+10%	+$50.4K	0.02%	625
2025 Q4	$523K	Sell	10,284 -1,151	-10%	-$58.9K	0.03%	548
2025 Q3	$635K	Sell	11,435 -10,069	-47%	-$589K	0.03%	405
2025 Q2	$1.48M	Sell	21,504 -2,257	-9%	-$154K	0.1%	146
2025 Q1	$1.65M	Sell	23,761 -1,518	-6%	-$125K	0.13%	111
2024 Q4	$2.17M	Sell	25,279 -1,590	-6%	-$172K	0.2%	83
2024 Q3	$3.2M	Sell	26,869 -1,136	-4%	-$152K	0.28%	63
2024 Q2	$4M	Buy	28,005 +243	+0.9%	+$32.2K	0.37%	50
2024 Q1	$3.56M	Sell	27,762 -47	-0.2%	-$5.59K	0.34%	53
2023 Q4	$2.88M	Buy	27,809 +4,612	+20%	+$456K	0.29%	59
2023 Q3	$2.11M	Buy	+23,197	New	+$2.04M	0.26%	59

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Syon Capital's NVO Position: Q2 2026 in Review

Syon Capital reduced its Novo Nordisk (NVO) stake by 25% in Q2 2026, selling an estimated $120K and leaving 8,565 shares worth $411K. The position accounts for 0.02% of the portfolio, ranked #702.

Syon Capital first reported a position in NVO in Q3 2023 and has held it in 12 quarters since. The position peaked at $4M in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Syon Capital held 8,565 shares of Novo Nordisk worth $411K as of Q2 2026.
Syon Capital sold 2,783 Novo Nordisk shares in Q2 2026, an estimated $120K.
Novo Nordisk made up 0.02% of Syon Capital's portfolio in Q2 2026, its #702 holding.
Syon Capital first reported a position in Novo Nordisk in Q3 2023 and has held it in 12 quarters since.
Syon Capital's Novo Nordisk position peaked at $4M in Q2 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.